BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37858311)

  • 1. Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes.
    Levina A; Uslan C; Murakami H; Crans DC; Lay PA
    Inorg Chem; 2023 Oct; 62(43):17804-17817. PubMed ID: 37858311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanadium Chloro-Substituted Schiff Base Catecholate Complexes are Reducible, Lipophilic, Water Stable, and Have Anticancer Activities.
    Murakami HA; Uslan C; Haase AA; Koehn JT; Vieira AP; Gaebler DJ; Hagan J; Beuning CN; Proschogo N; Levina A; Lay PA; Crans DC
    Inorg Chem; 2022 Dec; 61(51):20757-20773. PubMed ID: 36519680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanadium(V) Pyridine-Containing Schiff Base Catecholate Complexes are Lipophilic, Redox-Active and Selectively Cytotoxic in Glioblastoma (T98G) Cells.
    Kostenkova K; Levina A; Walters DA; Murakami HA; Lay PA; Crans DC
    Chemistry; 2023 Dec; 29(68):e202302271. PubMed ID: 37581946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(v) catecholate complexes.
    Crans DC; Koehn JT; Petry SM; Glover CM; Wijetunga A; Kaur R; Levina A; Lay PA
    Dalton Trans; 2019 May; 48(19):6383-6395. PubMed ID: 30941380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Short-Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections.
    Levina A; Pires Vieira A; Wijetunga A; Kaur R; Koehn JT; Crans DC; Lay PA
    Angew Chem Int Ed Engl; 2020 Sep; 59(37):15834-15838. PubMed ID: 32598089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
    Le M; Rathje O; Levina A; Lay PA
    J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadium(V) tris-3,5-di-tert-butylcatecholato complex: Links between speciation and anti-proliferative activity in human pancreatic cancer cells.
    Griffin E; Levina A; Lay PA
    J Inorg Biochem; 2019 Dec; 201():110815. PubMed ID: 31520878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of noninnocent metal complexes using solid-state NMR spectroscopy: o-dioxolene vanadium complexes.
    Chatterjee PB; Goncharov-Zapata O; Quinn LL; Hou G; Hamaed H; Schurko RW; Polenova T; Crans DC
    Inorg Chem; 2011 Oct; 50(20):9794-803. PubMed ID: 21842875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanadium(V/IV)-Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells.
    Levina A; Lay PA
    Inorg Chem; 2020 Nov; 59(22):16143-16153. PubMed ID: 32578416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanadium(V) complexes of a tripodal ligand, their characterisation and biological implications.
    Maurya MR; Uprety B; Avecilla F; Adão P; Costa Pessoa J
    Dalton Trans; 2015 Oct; 44(40):17736-55. PubMed ID: 26399883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanadium-based, extended catalytic lifetime catechol dioxygenases: evidence for a common catalyst.
    Yin CX; Finke RG
    J Am Chem Soc; 2005 Jun; 127(25):9003-13. PubMed ID: 15969577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
    Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
    J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity and Speciation of Anti-Diabetic Vanadium Complexes in Whole Blood and Its Components: The Important Role of Red Blood Cells.
    Levina A; McLeod AI; Gasparini SJ; Nguyen A; De Silva WG; Aitken JB; Harris HH; Glover C; Johannessen B; Lay PA
    Inorg Chem; 2015 Aug; 54(16):7753-66. PubMed ID: 26230577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells.
    Nunes P; Correia I; Cavaco I; Marques F; Pinheiro T; Avecilla F; Pessoa JC
    J Inorg Biochem; 2021 Apr; 217():111350. PubMed ID: 33477088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
    Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
    Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ancillary Ligand on Electronic Structure as Probed by
    Goncharova-Zapata O; Chatterjee PB; Hou G; Quinn LL; Li M; Yehl J; Crans DC; Polenova T
    CrystEngComm; 2013 Nov; 15(43):. PubMed ID: 24353476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear and dinuclear monoperoxovanadium(v) complexes with a hetero ligand. 1.(1) Self-decomposition reaction, detection of reactive oxygen species, and oxidizing ability.
    Kanamori K; Nishida K; Miyata N; Shimoyama T; Hata K; Mihara C; Okamoto K; Abe Y; Hayakawa S; Matsugo S
    Inorg Chem; 2004 Nov; 43(22):7127-40. PubMed ID: 15500351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
    Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
    Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex.
    Patra SA; Mohanty M; Banerjee A; Kesarwani S; Henkel F; Reuter H; Dinda R
    J Inorg Biochem; 2021 Nov; 224():111582. PubMed ID: 34450411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V
    Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N
    Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.